Patients with combined NOD2 and MEFV variants were identified in 4 patients who experienced a higher proportion of headaches (75% vs. 9.1%), chest pain (50% vs. 9.1%), myalgia (75% vs. 36.4%), and weight loss (50% vs. 36.4%). The gene discussed is NOD2; the disease is Myalgia.